NEW research employing Mendelian randomisation (MR) analysis has identified a potential causal relationship between lipid ...
The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.
A medical expert explained the non-pharmaceutical ways to lower cholesterol levels after a patient said they didn't like the ...
A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...
HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2-C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), and lipoprotein (a) (Lp(a)) were determined. Results: In study 1 ...
Nightingale Health Group's Half-year report 1 July 2024 - 31 December 2024 (unaudited) Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States ...
R&D expenses for the year ended December 31, 2024 were $70.3 million, compared with $73.0 million for the same period of 2023. Total R&D employee-related costs reduced by $4.2 million which was ...
Meanwhile, low estrogen levels can raise your levels of total cholesterol along with “bad” types of lipids, LDL and Apo B. 12. You’re gaining weight. Conventional wisdom holds that eating less = ...
The walnut eaters also had nearly a 6% decrease in apolipoprotein B, which is an indicator of how many LDL particles are in your blood. Elevated apolipoprotein B is a major risk factor for heart ...
Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...
EDT Apollo Global (APO) exploring $4B sale of Cox Media Group, Bloomberg reportsLight Up your Portfolio with Spark:Easily identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results